COVID-19疫苗诱发的免疫血栓性血栓性缺血症:一个审查
Siti Nur Atikah Aishah Suhaimi1, Izzati Abdul Halim Zaki1,2, Zakiah Mohd Noordin1,2
1Department of Pharmacy Practice, Universiti Teknologi MARA Selangor Branch, Bandar Puncak Alam, Malaysia.
Clinical and experimental vaccine research
|November 29, 2023
概括
疫苗诱发的免疫血栓性血栓性缺血症 (VITT) 是一种罕见但严重的疾病,与病毒载体COVID-19疫苗有关. 早期识别和特定的治疗方法,如IV免疫球蛋白和抗凝剂,对于患者的治疗结果至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 在接种COVID-19疫苗后,报告了罕见的血栓性事件与血栓缩,称为疫苗诱导的免疫血栓性血栓缩 (VITT).
- 这些事件特别在接受复制缺陷的腺病毒载体基础严重急性呼吸综合征冠状病毒2疫苗的人群中被注意到.
研究的目的:
- 综合审查和总结COVID-19疫苗接种后关于VITT的报告研究.
- 确定VITT的患病率,临床特征和管理策略.
主要方法:
- 在2021年10月1日之前,使用PubMed和SCOPUS进行了系统的文献搜索.
- 根据PRISMA指南进行了选和选择,最终分析包括29项研究.
主要成果:
- VITT病例主要与病毒载体疫苗有关:阿斯特拉泽内卡 (95%) 和詹森 (4%).
- 大脑静脉鼻血栓是最严重的表现 (70.4%),头痛是最常见的初始症状.
- 静脉注射免疫球蛋白和非肝素抗凝剂是主要的治疗选择.
结论:
- 本综述有助于医疗专业人员早期识别VITT,了解临床表现,诊断标准和管理.
- 新兴的知识和精细的指导方针对于改善VITT患者的治疗结果至关重要.
- 需要进一步的大规模试验来澄清这种联系和安全性.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...


